Essity Calls a Global Creative Review Across Its Enlarged Femcare Portfolio
Essity has kicked off a global creative review after major US femcare acquisitions expanded its stable well beyond Bodyform/Libresse to include Playtex, o.b., Carefree and Stayfree — putting one of adland's most celebrated accounts into play.
An M&A-Driven Review of a Landmark Account
The review follows Essity's acquisition of Edgewell femcare brands — Playtex, o.b., Carefree and Stayfree — in North America, plus the same brands in Brazil from Kenvue. A bigger, more complex portfolio has triggered a rethink of how the creative work is structured.
Essity kept it low-key, saying only that 'creative partnerships are kept under regular review.' But the stakes are high: this is the home of some of the most awarded femcare work in the industry.
Why This Account Matters So Much
AMV BBDO has worked with Essity since 2014 and won four Cannes Grand Prix for 'Wombstories' in 2021, following the category-defining 'Blood Normal.' BBH, meanwhile, holds the incoming Edgewell US brands — so the review is partly about which shop leads an enlarged roster.
For any agency, retaining or winning work of this creative pedigree is about more than fees; it's a showreel and a talent magnet. That's what makes a review like this reverberate far beyond the client.
How Acquisitions Reshape Agency Rosters
When a brand owner buys competitors, it inherits their agency relationships — and rarely keeps all of them. Consolidation reviews are the predictable next step, and they can move nine-figure sums of billings between holding companies overnight.
For marketers, the lesson is that M&A isn't just a finance event; it's a marketing-operations event. Whoever plans the integration of brand and agency relationships fastest tends to protect the most value.
Marketing Minute's Read
Creative reputation is fragile and portable. Essity's femcare work changed how an entire category talks about women's bodies — and that equity now has to survive a reshuffle. The brands that come through best will protect the creative platform, not just the agency line-item.
If you're integrating acquired brands, treat the creative idea as an asset to be preserved, and decide early who owns the enlarged relationship. Ambiguity is where great work goes to die.
Quick FAQ
Why is Essity reviewing its creative agencies?
Because acquisitions of Edgewell femcare brands (Playtex, o.b., Carefree, Stayfree) in North America and Brazil have expanded its portfolio, prompting a global review of how the creative work is structured.
Which agencies are involved?
AMV BBDO has held Essity's femcare work since 2014 (winning four Cannes Grand Prix for 'Wombstories'), while BBH holds the incoming Edgewell US brands — so the review partly decides who leads an enlarged roster.
Why does this account matter?
It's home to some of adland's most celebrated femcare work, including 'Wombstories' and 'Blood Normal,' making it a prized, reputation-defining piece of business.
Reviews like this are really about reputation, not just fees. Essity's femcare work rewired how a whole category talks about women's bodies, and that kind of equity is fragile when portfolios get reshuffled. The winners here will be whoever protects the creative platform, not whoever cuts the best rate card. — Daniel Nikolla, Founder of Merx Marketing
The takeaway: when acquisitions reshuffle a brand portfolio, treat the creative idea as an asset to preserve and decide early who owns the enlarged relationship — ambiguity is where great work dies.
When a business buys its rivals, should it consolidate all the creative work — or protect the best of what it inherits?
If you would like to know more about this topic, please contact us on danieln@merxmarketing.co.uk
Sources: Campaign; More About Advertising.
Related reading
Written by Daniel Nikolla, Founder of Merx Marketing Ltd and Marketing Minute
Comments